Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy

NCT00328588 is registered in ClinicalTrials.gov with Astellas Pharma Inc as lead sponsor.

NCT NCT00328588
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00328588 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
LUCY: A Study for the Treatment of Non-Small Cell Lung Cancer (NSCLC) in Patients Previously Treated With Chemotherapy
Lead sponsor
Astellas Pharma Inc
Phase
Phase 2
Overall status
Completed
Start date
December 31, 2006
Completion date
March 31, 2007
Enrollment
37 (actual)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

cancer of lung, cancer of the lung, carcinoma, non-small cell lung, lung cancer, non-small cell lung carcinoma